Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.
Impact
If passed, S3831 will allow individuals enrolled in the Medicaid program and the Plan First program to receive coverage for fertility preservation services. This includes procedures designed to protect reproductive potential, such as the storage of sperm, eggs, or embryos, which fall under standards established by medical authorities and guidelines. This move is particularly significant for low-to-moderate-income patients who may not be able to afford such services otherwise, representing an essential step in equitable access to reproductive healthcare.
Summary
Senate Bill 3831 (S3831) introduced in New Jersey aims to enhance healthcare provision under the state's Medicaid program by mandating coverage for standard fertility preservation services. This bill specifically addresses cases where medically necessary treatments, such as surgery or chemotherapy, could lead to iatrogenic infertility—infertility that is a side effect of medical treatment. By implementing these provisions, the bill ensures that individuals facing these risks will have access to necessary reproductive health services that are often prohibitively expensive.
Contention
There might be points of contention surrounding this bill, particularly concerning the additional costs it could impose on state healthcare budgets due to Medicaid coverage expansion. Opponents of similar measures have historically raised concerns over financial implications, suggesting that expanding services could lead to higher state expenditures. Additionally, there may be debates within the legislature about prioritizing funds for reproductive health services in light of other pressing healthcare needs.
Insurance; medically necessary expenses for standard fertility preservation services when a medically necessary treatment for cancer, sickle cell disease, or lupus may directly or indirectly cause iatrogenic infertility; require coverage
Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Infertility treatment and standard fertility preservation services coverage by health plans requirement, MinnesotaCare and medical assistance coverage of infertility treatment and standard fertility preservation services requirement, and appropriation